切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2022, Vol. 15 ›› Issue (03) : 339 -343. doi: 10.3877/cma.j.issn.1674-6902.2022.03.011

论著

广州地区非结核分枝杆菌肺病微生物及临床特征分析
赖宁1,(), 庄泽钦1, 钟典1   
  1. 1. 510120 广州,广州医科大学附属第一医院,广州呼吸健康研究院,呼吸疾病国家重点实验室,国家呼吸系统疾病临床医学研究中心
  • 收稿日期:2021-10-05 出版日期:2022-06-25
  • 通信作者: 赖宁

Analysis of microbiological and clinical characteristic of non-tuberculous Mycobacteria related pulmonary diseases in Guangzhou

Ning Lai1,(), Zeqin Zhuang1, Dian Zhong1   

  1. 1. The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou 510120, China
  • Received:2021-10-05 Published:2022-06-25
  • Corresponding author: Ning Lai
引用本文:

赖宁, 庄泽钦, 钟典. 广州地区非结核分枝杆菌肺病微生物及临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2022, 15(03): 339-343.

Ning Lai, Zeqin Zhuang, Dian Zhong. Analysis of microbiological and clinical characteristic of non-tuberculous Mycobacteria related pulmonary diseases in Guangzhou[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(03): 339-343.

目的

分析广州地区不同非结核分枝杆菌(NTM)与其所致肺病的临床特征。

方法

选择2016年1月至2020年12月广州地区的112例NTM肺病患者,分析NTM患者的症状、影像学特征及易感因素。

结果

112例NTM肺病患者中,男性年龄>50岁占78.7%(48/61),女性年龄>50岁占84.3%(43/51),NTM感染与患者年龄高度相关(r=0.16,P=0.018)。胞内分枝杆菌80例(71.4%)。男性患者更易出现咳嗽症状(48/61)(χ2=3.27,P=0.03),而女性患者更易出现咯血症状(14/51)(χ2=5.39,P=0.021)。年龄大的患者更易出现咯血(16/91)(r=0.21,P=0.015),而年轻患者更易出现气短症状(10/21)(r=0.17,P=0.023)。NTM肺部疾病最常见的影像学特征是支气管扩张,占40.2%(45/112),肺部结节占36.6%(41/112),多发空洞38.4%(43/112)。NTM感染最常见的易患因素为MTB,占66.1%(74/112);其次为支气管扩张占25.0%(28/112),合并COPD占17.9%(20/112)。与女性患者相比,男性患者更易合并COPD(OR=5.23,95%CI 5.20~72.60);胞内分枝杆菌感染更易合并支气管扩张(OR=0.13,95%CI 0.09~0.86)。

结论

广州地区NTM感染最常见的病原体是胞内分枝杆菌。NTM感染与患者年龄相关,最常见的影像学表现是支气管扩张、结节影及多发性空洞。MTB感染及器官移植是NTM感染的高危因素。

Objective

To analyze the clinical characteristic relevance between different non-tuberculous mycobacteria (NTM) and NTM related pulmonary diseases (NTM-PD) in Guangzhou.

Methods

We performed a retrospective analysis of 112 NTM-PD patients in Guangzhou from January 2016 to December 2020, analyzing the symptom, radiological characteristic, and risk factor of all NTM-PD patients.

Results

In all 112 NTM-PD patients, the age of 78.7% (48/61) male patients and 84.3% (43/51) female patients was over 50. NTM infection was also highly related with the age of patient (r=0.16, P=0.018). 71.4% (80) patients were infected with M. intracellulare in all 112 NTM-PD patients. Male patients (61) were more likely to have cough (48) (χ2=3.27, P=0.03), but female patients (51) were more likely to have hemoptysis (14) (χ2=5.39, P=0.021). The older patients (91) were more likely to have hemoptysis (16) (r=0.21, P=0.015) , but the younger patients (21) were more likely to have shortness of breath (10) (r=0.17, P=0.023). The most common radiological presentation of NTM-PD was bronchiectasis 40.2% (45/112), pulmonary nodule 36.6% (41/112), multiple cavities 38.4% (43/112). The most common risk factor of NTM infection was tuberculosis 66.1% (74/112), bronchiectasis 25.0% (28/112), COPD 17.9% (20/112). Compared with female patients, male patients were more likely to have COPD (OR=5.23, 95%CI 5.20~72.60). The patients infected with M. intracellulare were more likely to have bronchiectasis (OR=0.13, 95%CI 0.09~0.86).

Conclusion

The most common pathogenic NTM species was M. intracellulare in Guangzhou. NTM infection was highly related with the age of patient. The most common radiological presentation of NTM-PD was bronchiectasis, pulmonary nodule, and multiple cavities. Tuberculosis infection and organ transplantation were also high risk factor of NTM infection.

表1 112例广州地区NTM肺病患者的病原体分布情况(n)
表2 112例NTM肺病患者的临床症状与不同NTM之间的关系(n)
表3 112例NTM肺病患者的影像学表现与不同种类NTM之间的关系(n)
表4 易感因素与不同NTM之间的关系(n)
表5 NTM感染和NTM定植患者的临床特征、影像学特征和易患因素比较
1
Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the american thoracic society was approved by the board of directors, march 1997. Medical section of the american lung association[J]. Am J Respir Crit Care Med, 1997, 156(2 Pt 2): S1-S25.
2
D Rebecca Prevots, Pamela AS, Daniel S, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems[J]. Am J Respir Crit Care Med, 2010182(7): 970-976.
3
Seung JK, Soon PS. Increasing burden of nontuberculous Mycobacteria in Korea[J]. J Korean Med Sci, 2017, 32(8): 1215-1216.
4
Ho N, Atsuyuki K, Kozo M, et al. Epidemiology of pulmonary nontuberculous Mycobacterial disease, Japan[J]. Emerg Infect Dis, 2016, 22(6): 1116-1117.
5
David EG, Timothy A, Brown-Elliott Barbara A,et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases[J]. Am J Respir Crit Care Med, 2007, 175(4): 367-416.
6
赵雁林,逄 宇. 结核病实验室检验规程[M]. 北京:人民卫生出版社,2015: 38-42.
7
Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome[J]. Chest, 1992, 101(6): 1605-1609.
8
Neeraj MS, Jennifer AD, Laura FA, et al. Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012[J]. BMC Infect Dis, 2016, 16: 195.
9
Duan HF, Han XQ, Wang QF, et al. Clinical significance of nontuberculous Mycobacteria isolated from respiratory specimens in a chinese tuberculosis tertiary care center[J]. Sci Rep, 2016, 3(6): 36299.
10
Furuuchi K, Ito A, Hashimoto T, et al. Clinical significance of the radiological severity score in Mycobacterium avium complex lung disease patients[J]. Int J Tuberc Lung Dis, 2017, 21(4): 452-457.
11
Jennifer A, Kenneth NO, D Rebecca Prevots. Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk[J]. Am J Respir Crit Care Med, 2014, 190(5): 581-586.
12
van Ingen J, Bendien SA, de Lange WCM, et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands[J]. Thorax, 2009, 64(6): 502-506.
13
Giulia B, Alberto P, Almerico M, et al. Nontuberculous Mycobacteria in noncystic fibrosis bronchiectasis[J]. Biomed Res Int, 2015, 2015: 197950.
14
Chu HQ, Zhao L, Xiao HQ, et al. Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis[J]. Arch Med Sci, 2014, 10(4): 661-668.
15
Jennifer RH, Vijaya K, Edward DC. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease[J]. Clin Chest Med, 2015, 36(1): 1-11.
16
Chan Edward D, Iseman Michael D. Underlying host risk factors for nontuberculous mycobacterial lung disease[J]. Semin Respir Crit Care Med, 2013, 34(1): 110-123.
17
Jennifer B, Elizabeth S, Fotios VM, et al. Incidence and risk factors for nontuberculous Mycobacterial infection after allogeneic hematopoietic cell transplantation[J]. Biol Blood Marrow Transplant, 2018, 24(2): 366-372.
18
F O′Toole R, Shukla SD, Walters EH. TB meets COPD: An emerging global co-morbidity in human lung disease[J]. Tuberculosis (Edinb), 2015, 95(6): 659-663.
19
Emily H, Kevin LW. Nontuberculous mycobacteria infections in immunosuppressed hosts[J]. Clin Chest Med, 2015, 36(1): 91-99.
20
Martiniano SL, Nick JA, Daley CL. Nontuberculous Mycobacterial infections in cystic fibrosis[J]. Thorac Surg Clin, 2019, 29(1): 95-108.
21
Martiniano SL, Nick JA, Daley CL. Nontuberculous Mycobacterial Infections in Cystic Fibrosis[J]. Clin Chest Med, 2016, 37(1): 83-96.
22
Adjemian J, Olivier KN, Prevots DR. Epidemiology of pulmonary nontuberculous Mycobacterial sputum positivity in patients with cystic fibrosis in the united States, 2010-2014[J]. Ann Am Thorac Soc, 2018, 15(7): 817-826.
23
Bar-On O, Mussaffi H, Mei-Zahav M, et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis[J]. J Cyst Fibros, 2015, 14(1): 53-62.
24
Martiniano SL, Esther CR, Haworth CS, et al. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis[J]. Pediatr Pulmonol, 2020, 55(2): 521-525.
25
Lu M, Saddi V, Britton PN, et al. Disease caused by non-tuberculous mycobacteria in children with cystic fibrosis[J]. Paediatr Respir Rev, 2019, 29: 42-52.
[1] 张焱, 刘春媚, 姚瑾, 陈苗苗, 徐雯, 黄品同. 超声O-RADS分类和临床特征对不同病理类型卵巢浆液性肿瘤的诊断价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(03): 268-274.
[2] 顾盼盼, 董传莉, 宋梦瑶, 瞿色华, 杨小迪, 周瑞. 不完全性川崎病患儿临床特征及冠状动脉损害情况分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 446-451.
[3] 丁科, 张亚琼, 刘杰, 邓莉平, 张永喜, 熊勇. 获得性免疫缺陷综合征相关淋巴瘤患者的临床特征及生存状况的变化趋势[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 278-284.
[4] 张超, 张珍, 马梁, 穆欢欢, 刘彩玲. 腹腔镜胰十二指肠切除术术后C级胰瘘患者临床特征及影响因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 675-678.
[5] 颜晓敏, 崔嵘嵘. 23例乳腺佩吉特病的经验交流[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 353-354.
[6] 高佳, 姜吉询, 王鑫, 吴婷, 向江明. 病理性乳头溢液单中心临床分析附168例报告[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 323-326.
[7] 王华, 曹素娥, 吴建杰, 狄金明. 膀胱炎性肌纤维母细胞瘤四例诊治报告并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 547-552.
[8] 杨柳, 陈佳, 孙雅娟, 陈娇, 谭明超, 龚明福. 抗中性粒细胞胞浆抗体相关性血管炎的胸部CT 及临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 744-749.
[9] 杨攀, 黄晓寒, 邓才霞, 周利航, 周向东, 罗虎. SMARCA4缺失的胸部未分化肿瘤临床特征及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 529-534.
[10] 何俊, 易淑华, 陈婷婷, 杨玉, 李红雨, 谢飞, 何健. 妊娠并发社区获得性肺炎临床特征及降钙素原和炎症指数对其诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 421-425.
[11] 李广林, 唐凯, 卢秀珍. 部分调节性内斜视的临床研究进展[J/OL]. 中华眼科医学杂志(电子版), 2024, 14(03): 177-181.
[12] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[13] 邓屹, 叶苏意, 崔伟, 乐艳青, 陈兢兢, 陈俞溪, 陈泳衡, 许荣德, 李静. 影像引导下经皮肺穿刺活检的研究进展[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 296-302.
[14] 刘昌恩, 李岩, 张其德. 基于内镜筛查发现的自身免疫性胃炎的临床特征分析[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 233-237.
[15] 王宇, 张泽锴, 吴明胜, 王高祥, 孙效辉, 王君, 徐美青, 李田, 徐世斌, 解明然. 术后病理诊断为良性肺结节323例患者临床特征分析[J/OL]. 中华胸部外科电子杂志, 2024, 11(03): 167-174.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?